Ouch, Pfizer is getting hit hard on what appears to be the impending commercial failure of Exubera, the first-ever market-ready inhalable insulin. On Monday, BrandWeek (the marketing industry’s premiere weekly publication) called it the “Billion-Dollar Bong“:
“Last year, Pfizer paid Sanofi-Aventis $1.4 billion for Exubera, a new inhaled insulin product for diabetics that Pfizer forecast would [...]

Read more »

Meet Alberto Pugliese, M.D., a Research Associate Professor of Medicine, Immunology and Microbiology, and Head of the Immunogenetics Program at the Diabetes Research Institute in Miami, FL.  He was scheduled to host a chat on “Reversing Autoimmunity” on the DiabetesTalkFest site on Feb. 8, but some technical difficulties prevented him from logging on.  So he [...]

Read more »

Some valuable nuggets I unearthed last week:
* Anyone heard of the new print magazine called Diabetes Explorer?  It’s a bright, colorful 6x/year glossy that focuses on “brief, useful ‘hands-on’ articles,” editor Kathy Spain tells me.  Looks pretty neat, although I was surprised to learn that anyone’s launching a new paper-based publication in this increasingly [...]

Read more »

The day unimagined has arrived:  I am a pumper.  I am woman, I wear Pod.  I can’t believe I haven’t injected myself in 3 entire days! 
So far it’s so existence-altering, I hardly know where to begin…  In fact, I’m trying to temper my enthusiasm, so I don’t peter out too fast. Meaning I’m reserving my [...]

Read more »

Mark Sisson’s Daily Apple blog carries the tagline: “Doing my part to piss off the self-righteous health establishment.” Obviously, he prides himself on stirring the pot — or shaking the tree, as his metaphor would have it.
Among other outspoken claims, Mark recently wrote that diabetes is “a made-up, stupid disease” — called to my attention [...]

Read more »